Crossmark

Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed

Crossref DOI link: https://doi.org/10.1007/s00296-021-04969-2

Published Online: 2021-08-19

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Daoussis, Dimitrios https://orcid.org/0000-0001-8027-3655
Leonidou, Lydia https://orcid.org/0000-0003-4167-2746
Kalogeropoulou, Christina https://orcid.org/0000-0002-9725-1791
Paliogianni, Fotini https://orcid.org/0000-0001-5112-1724
Tzouvelekis, Argyrios https://orcid.org/0000-0002-6295-1384
License Information

Text and Data Mining valid from 2021-08-19

Version of Record valid from 2021-08-19
More Information

Article History

Received: 9 June 2021

Accepted: 7 August 2021

First Online: 19 August 2021

Free to read: This content has been made available to all.